This suggests that the PLK1-FOXO1 pathway may be exploited as a new therapeutic strategy to reactivate the FOXO1-mediated apoptotic signaling networks and efficiently kill human advanced PCa cells. This evidence concerns the gene FOXO1 and posterior cortical atrophy.